anonymous
Guest
anonymous
Guest
but retatrutide has GIP too, so it will be the same issues...GIP promotes atherosclerotic plaque formation, it seems, negating the effects of GLP1. Be prepared for bad news on our CVOT. Why Ricks (gag) is already onto talking about retatrutide and orfoglipron.